We are live on ! Find out more
NPTN

NEOPHOTONICS CORP

Delisted

NPTN was delisted on the 2nd of August, 2022.

92 hedge funds and large institutions have $224M invested in NEOPHOTONICS CORP in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more call options, than puts

Call options by funds: $4.86M | Put options by funds: $1.93M

14% more capital invested

Capital invested by funds: $196M → $224M (+$27.8M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 31

5% less funds holding

Funds holding: 9792 (-5)

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

Holders
92
Holders Change
-5
Holders Change %
-5.15%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
15
Increased
31
Reduced
31
Closed
19
Calls
$4.86M
Puts
$1.93M
Net Calls
+$2.93M
Net Calls Change
+$8K
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.63M -$34.3K -5,617 -2%
NIM
27
Needham Investment Management
New York
$1.38M +$183K +30,000 +17%
Deutsche Bank
28
Deutsche Bank
Germany
$1.18M +$768K +125,720 +236%
Morgan Stanley
29
Morgan Stanley
New York
$948K -$671K -109,860 -43%
HIM
30
Herald Investment Management
United Kingdom
$922K
Charles Schwab
31
Charles Schwab
California
$882K -$102K -16,660 -11%
Group One Trading
32
Group One Trading
Illinois
$868K +$755K +123,621 +1,481%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$819K -$134K -21,871 -15%
GC
34
Guggenheim Capital
Illinois
$692K -$672 -110 -0.1%
Goldman Sachs
35
Goldman Sachs
New York
$673K -$236K -38,687 -27%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$661K +$454K +74,370 +286%
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$550K +$423K +69,300 +485%
PPA
38
Parametric Portfolio Associates
Washington
$548K +$121K +19,841 +31%
TCIM
39
TIAA CREF Investment Management
New York
$529K +$7.62K +1,247 +2%
P8IP
40
Pier 88 Investment Partners
California
$526K +$112K +18,365 +30%
Wells Fargo
41
Wells Fargo
California
$427K +$130K +21,238 +49%
TA
42
Teachers Advisors
New York
$399K
Simplex Trading
43
Simplex Trading
Illinois
$384K +$307K +50,282 +618%
Squarepoint
44
Squarepoint
New York
$366K +$340K +55,630 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$342K +$7.46K +1,222 +2%
Invesco
46
Invesco
Georgia
$335K -$2.51K -411 -0.8%
AllianceBernstein
47
AllianceBernstein
Tennessee
$295K
PCM
48
Prelude Capital Management
New York
$262K +$32.8K +5,363 +16%
BFM
49
Boothbay Fund Management
New York
$247K
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$219K -$32.6K -5,344 -14%

NPTN Hedge Fund Activity: Q4 2017 in Review

92 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in NEOPHOTONICS CORP (NPTN) for Q4 2017, worth a combined $224M — up 14% from $196M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of NPTN and 15 opened new positions — a net loss of 4 holders — while 31 trimmed existing stakes and 31 added.

The largest buyer was Citadel Advisors, adding an estimated $3.94M. The largest seller was Lombard Odier Asset Management (USA), cutting an estimated $8.96M.

  • 92 institutional investors held NEOPHOTONICS CORP (NPTN) as of Q4 2017, down from 97 in Q3 2017.
  • Funds reported $224M of NEOPHOTONICS CORP stock for Q4 2017, up 14% quarter-over-quarter.
  • 15 funds opened new NEOPHOTONICS CORP positions in Q4 2017 and 19 closed out, a net change of -4 holders.
  • The largest NEOPHOTONICS CORP buyer in Q4 2017 was Citadel Advisors, an estimated $3.94M added.
  • The largest NEOPHOTONICS CORP seller in Q4 2017 was Lombard Odier Asset Management (USA), an estimated $8.96M sold.

Based on aggregated 13F filings for Q4 2017.